Call for Submissions of Abstracts for Oral Presentations
The 20th Edition of Music City SCALE will be held on May 14-18, 2025 in Nashville, TN. This is a call for Oral Presentation Abstract Submissions in aesthetic topics or medical dermatology. If your abstract is selected, you will be either invited to give a 5-minute presentation at the 2025 SCALE Meeting or if you are not selected for an oral presentation you will be invited to display your work as a digital poster in the SCALE digital poster hall.
Please note that abstracts submitted for consideration of oral presentation must follow CME guidelines and be free of commercial influence (logos, branded slides, marketing names of devices/drugs, etc). If your abstract is selected you will be required to complete a disclosure form and have your presentation content reviewed by the accredited provider prior to the meeting.
Selected abstract presenters may not be employees of ineligible companies as defined by the ACCME.
Important Dates:
Abstract Submission Deadline
December 31, 2024
Abstract Acceptance Notification
January 30, 2025
Abstract Submission Instructions
Please read through the submission instructions below before preparing your abstract:
- Please consider the Abstract Guidelines when writing your abstract.
- Review the Acceptance and Presentation Process for abstracts.
- Submit your Abstract via the online Submission form.
ABSTRACT GUIDELINES
Content Guidelines
Abstracts can only be accepted electronically and must adhere to the following guidelines:
- Abstracts are limited to 500 words. (Word count excludes the abstract title, author names, affiliations, and any supplementary materials such as a photo or graph.)
- Abstracts must be divided into sections: Title, Background/Synopsis, Objectives/Purpose, Design/Methods, Results, and Conclusion that states the importance and potential implications of the observations.
- Abstracts must be proofread carefully to avoid errors before submission.
- Abstracts must contain generic drug names only.
- Abstracts must be submitted in clear English with accurate grammar and spelling of a quality suitable for publication.
- Lead authors must be prepared to disclose all financial relationships if abstract is selected for presentation.
- Selected abstract presenters may not be employees of ineligible companies as defined by the ACCME.
- Any funding support for the research must be disclosed.
- Encore research is eligible for submission but the original date and location of presentation of the research must be disclosed in the application.
Checklist
The purpose of the abstract is to define the precise subject of the presentation to an audience. Below you will find a checklist for your abstract preparation. All abstracts are considered equally for selection, and the quality of the abstract is the single most important factor in the Committee’s decision.
Please provide the following information:
- Title
- Background/Synopsis – A concise description of your subject matter and prior work in this area.
- Objective/Purpose – The question your material answers or the hypothesis that it tests.
- Design/Methods – The experimental design or technique employed.
- Results – Outcomes & measurements, with statistical significance, if appropriate
- Conclusion – Conclusions, clinical pertinence, and value or for Workshops and Presentations, the prevailing point of view.
- Proofread – Make sure to proofread your abstract. Misspellings and typographical errors reflect badly on your scientific work. Prepare to substitute plain text for special characters as these characters may not be rendered reliably (i.e., plus or minus for ±, alpha for a etc.)
Acceptance and Presentation Process
Abstracts are reviewed and selected by SCALE judges based on quality and merit. You will be notified by January 30, 2025 if your abstract is accepted.
*Expenses related to airfare, lodging, and social events/guest fees are the responsibility of the presenter.